###begin article-title 0
Metabolism of Low-Dose Inorganic Arsenic in a Central European Population: Influence of Sex and Genetic Polymorphisms
###end article-title 0
###begin p 1
The authors declare they have no competing financial interests.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
There is a wide variation in susceptibility to health effects of arsenic, which, in part, may be due to differences in arsenic metabolism. Arsenic is metabolized by reduction and methylation reactions, catalyzed by reductases and methyltransferases.
###end p 3
###begin title 4
Objectives
###end title 4
###begin p 5
Our goal in this study was to elucidate the influence of various demographic and genetic factors on the metabolism of arsenic.
###end p 5
###begin title 6
Methods
###end title 6
###begin p 7
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 304 305 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
We studied 415 individuals from Hungary, Romania, and Slovakia by measuring arsenic metabolites in urine using liquid chromatography with hydride generation and inductively coupled plasma mass spectrometry (HPLC-HG-ICPMS). We performed genotyping of arsenic (+III) methyltransferase (AS3MT), glutathione S-transferase omega 1 (GSTO1), and methylene-tetrahydrofolate reductase (MTHFR).
###end p 7
###begin title 8
Results
###end title 8
###begin p 9
###xml 60 65 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 110 115 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 564 569 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 469 474 <span type="species:ncbi:9606">women</span>
###xml 504 507 <span type="species:ncbi:9606">men</span>
###xml 631 634 <span type="species:ncbi:9606">men</span>
###xml 643 648 <span type="species:ncbi:9606">women</span>
The results show that the M287T (T-->C) polymorphism in the AS3MT gene, the A222V (C-->T) polymorphism in the MTHFR gene, body mass index, and sex are major factors that influence arsenic metabolism in this population, with a median of 8.0 mug/L arsenic in urine. Females < 60 years of age had, in general, higher methylation efficiency than males, indicating an influence of sex steroids. That might also explain the observed better methylation in overweight or obese women, compared with normal weight men. The influence of the M287T (T-->C) polymorphism in the AS3MT gene on the methylation capacity was much more pronounced in men than in women.
###end p 9
###begin title 10
Conclusions
###end title 10
###begin p 11
###xml 103 106 <span type="species:ncbi:9606">men</span>
###xml 149 154 <span type="species:ncbi:9606">women</span>
The factors investigated explained almost 20% of the variation seen in the metabolism of arsenic among men and only around 4% of the variation among women. The rest of the variation is probably explained by other methyltransferases backing up the methylation of arsenic.
###end p 11
###begin p 12
###xml 239 282 239 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-ehp0115-001081">Internal Agency for Research on Cancer 2004</xref>
###xml 284 320 284 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60-ehp0115-001081">World Health Organization (WHO) 2001</xref>
###xml 403 433 403 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37-ehp0115-001081">National Research Council 2001</xref>
###xml 517 528 517 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55-ehp0115-001081">Vahter 2002</xref>
Arsenic is a worldwide water contaminant, and chronic exposure has been associated with a large number of health effects, such as different forms of cancer, skin lesions, vascular diseases, liver- and neurotoxicity, and diabetes mellitus [Internal Agency for Research on Cancer 2004; World Health Organization (WHO) 2001]. A wide variation in susceptibility to various health effects has been reported (National Research Council 2001), which, in part, may be due to the marked variation in the metabolism of arsenic (Vahter 2002).
###end p 12
###begin p 13
###xml 179 190 179 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55-ehp0115-001081">Vahter 2002</xref>
###xml 279 299 279 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp0115-001081">Hayakawa et al. 2005</xref>
###xml 331 355 331 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35-ehp0115-001081">Naranmandura et al. 2006</xref>
###xml 490 491 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 579 587 579 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-ehp0115-001081">Figure 1</xref>
###xml 673 698 673 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9-ehp0115-001081">Delnomdedieu et al. 1994a</xref>
###xml 700 705 700 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10-ehp0115-001081">1994b</xref>
###xml 707 724 707 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48-ehp0115-001081">Scott et al. 1993</xref>
The classical pathway for the metabolism of inorganic arsenic (iAs) involves alternating reduction and oxidative methylation with only one end product, dimethylarsinate [DMA(V)] (Vahter 2002). Another-newly proposed-pathway suggests methylation of arsenic-glutathione complexes (Hayakawa et al. 2005) or arsenic bound to proteins (Naranmandura et al. 2006) with methyl-arsonate [MA(V)] and DMA(V) as end products. Both pathways involve methylation of arsenic via one-carbon metabolism with S-adenosyl methionine (SAM) as the methyl donor and requiring reduced glutathione (GSH) (Figure 1). GSH and probably other thiols serve as electron donors in the reduction reactions (Delnomdedieu et al. 1994a, 1994b; Scott et al. 1993), which are catalyzed by reductases.
###end p 13
###begin p 14
###xml 212 223 212 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55-ehp0115-001081">Vahter 2002</xref>
###xml 399 421 399 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-ehp0115-001081">Hughes and Kenyon 1998</xref>
###xml 525 551 525 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23-ehp0115-001081">Kligerman and Tennant 2006</xref>
###xml 553 572 553 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39-ehp0115-001081">Petrick et al. 2000</xref>
###xml 574 597 574 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46-ehp0115-001081">Schwerdtle et al. 2003a</xref>
###xml 599 604 599 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47-ehp0115-001081">2003b</xref>
###xml 606 624 606 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51-ehp0115-001081">Styblo et al. 2000</xref>
###xml 626 642 626 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b58-ehp0115-001081">Vega et al. 2001</xref>
###xml 757 777 757 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp0115-001081">Aposhian et al. 2000</xref>
###xml 779 793 779 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-ehp0115-001081">Le et al. 2000</xref>
###xml 795 813 795 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-ehp0115-001081">Mandal et al. 2001</xref>
###xml 815 837 815 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56-ehp0115-001081">Valenzuela et al. 2005</xref>
###xml 966 977 966 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55-ehp0115-001081">Vahter 2002</xref>
###xml 1328 1345 1328 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-ehp0115-001081">Chen et al. 2003a</xref>
###xml 1347 1352 1347 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-ehp0115-001081">2003b</xref>
###xml 1354 1358 1354 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-ehp0115-001081">2005</xref>
###xml 1360 1380 1360 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11-ehp0115-001081">Del Razo et al. 1997</xref>
###xml 1382 1399 1382 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-ehp0115-001081">Hsueh et al. 1997</xref>
###xml 1401 1422 1401 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27-ehp0115-001081">Maki-Paakkanen J 1998</xref>
###xml 1424 1445 1424 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49-ehp0115-001081">Steinmaus et al. 2006</xref>
###xml 1447 1461 1447 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61-ehp0115-001081">Yu et al. 2000</xref>
###xml 1640 1651 1640 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55-ehp0115-001081">Vahter 2002</xref>
###xml 1798 1809 1798 1809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53-ehp0115-001081">Vahter 1999</xref>
###xml 127 133 <span type="species:ncbi:9606">humans</span>
###xml 157 162 <span type="species:ncbi:9606">human</span>
###xml 1632 1638 <span type="species:ncbi:9606">humans</span>
###xml 1660 1666 <span type="species:ncbi:9606">people</span>
Following exposure to iAs by ingestion or inhalation, DMA(V) is the major metabolite found in urine in most mammals, including humans, but MA(V) is found in human urine and very rarely in urine of other mammals (Vahter 2002). The metabolism of iAs involves both detoxification (methylation) and activation (reduction). Although MA(V) and DMA(V) have a lower toxicity than inorganic arsenic species (Hughes and Kenyon 1998), the trivalent methylated metabolites are more reactive and toxic than the other arsenic metabolites (Kligerman and Tennant 2006; Petrick et al. 2000; Schwerdtle et al. 2003a, 2003b; Styblo et al. 2000; Vega et al. 2001). A series of studies reported the presence of methylarsonite [MA(III)] and dimethylarsinite [DMA(III)] in urine (Aposhian et al. 2000; Le et al. 2000; Mandal et al. 2001; Valenzuela et al. 2005), although high concentrations are not likely to be found in urine because the high reactivity renders them to bind in tissues (Vahter 2002). In contrast, it is reasonable to assume that the total amount of MA in urine reflects the formation of the highly toxic MA(III) in the body. This might explain the observed increasing prevalence of arsenic-related toxic effects (e.g., skin lesions, skin cancer, bladder cancer, chromosome aberrations) with an increasing percentage of MA in urine (Chen et al. 2003a, 2003b, 2005; Del Razo et al. 1997; Hsueh et al. 1997; Maki-Paakkanen J 1998; Steinmaus et al. 2006; Yu et al. 2000). Furthermore, experimental animals, most of which methylate arsenic efficiently to DMA with essentially no MA excretion, show a faster overall excretion of arsenic than humans (Vahter 2002). Also, people with a small percentage of urinary arsenic as MA show less retention of arsenic than those with a higher percentage of urinary MA (Vahter 1999).
###end p 14
###begin p 15
###xml 247 258 247 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54-ehp0115-001081">Vahter 2000</xref>
###xml 321 322 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 440 461 440 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62-ehp0115-001081">Zakharyan et al. 2001</xref>
###xml 603 608 603 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 628 633 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyt19</italic>
###xml 636 651 636 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-ehp0115-001081">Lin et al. 2002</xref>
###xml 809 814 809 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 817 825 817 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-ehp0115-001081">Figure 1</xref>
###xml 529 532 <span type="species:ncbi:10116">rat</span>
###xml 562 567 <span type="species:ncbi:9606">human</span>
Thus, it is essential to determine the reasons for the marked variation in the metabolism of arsenic between individuals and population groups. One reason could be genetic polymorphisms in the regulation of enzymes involved in arsenic metabolism (Vahter 2000). One arsenic-reductase has been identified to be glutathione-S-transferase omega (GSTO1), which is able to reduce both MA(V) to MA(III) and arsenate [As(V)] to arsenite [As(III)] (Zakharyan et al. 2001). Recently, a SAM-dependent arsenic methyl-transferase isolated in rat was found to be a homolog of human arsenic (+III) methyl-transferase (AS3MT; previously called Cyt19) (Lin et al. 2002). Enzymes involved in the one-carbon metabolism could also indirectly influence the metabolism of arsenic, for example, methylenetetrahydrofolate reductase (MTHFR) (Figure 1).
###end p 15
###begin p 16
Our aim in the present study was to elucidate the reasons for intraindividual variation in arsenic metabolism. Therefore, we studied the influence of age, sex, body mass index (BMI), genetic polymorphisms, and selenium status on the arsenic metabolite pattern in urine.
###end p 16
###begin title 17
Materials and Methods
###end title 17
###begin title 18
Study population
###end title 18
###begin p 19
###xml 697 717 697 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-ehp0115-001081">Lindberg et al. 2006</xref>
###xml 719 741 719 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52-ehp0115-001081">Thirumaran et al. 2006</xref>
###xml 950 962 <span type="species:ncbi:9606">participants</span>
This study is part of a case-control study concerning cancer risks in relation to low-level arsenic exposure via drinking water in Central Europe: Arsenic Health Risk Assessment and Molecular Epidemiology (ASHRAM). Study areas were defined as certain counties in Hungary (Bacs, Bekes, Csongrad, and Jazs-Nagykun-Szolnok), Romania (Bihor and Arad), and Slovakia (Banska Bystrica and Nitra) with known hotspots of arsenic in drinking water. The recruitment of skin, bladder, and kidney cancer cases and hospital-based controls with appendicitis, abdominal hernias, duodenal ulcer, cholelithiasis, and fractures, as well as the methods for collecting urine and blood samples, are described elswhere (Lindberg et al. 2006; Thirumaran et al. 2006). In short, all spot urine samples and whole blood samples, in spite of country, were collected and stored at -20degreesC and -80degreesC, respectively, until analysis. Informed consent was obtained from all participants, and the study was approved by the ethics committee of each hospital. In order to eliminate any potential bias caused by cancer, we selected controls for evaluation of factors that influence the metabolism of iAs.
###end p 19
###begin p 20
###xml 299 319 298 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-ehp0115-001081">Lindberg et al. 2006</xref>
There was a cluster of values close to 100% DMA at the lowest water arsenic concentrations. The intercept between the sum of urinary arsenic metabolites plotted against current water concentration was 2.5 mug/L, indicating a significant contribution of arsenic from food at the low exposure levels (Lindberg et al. 2006). Also, when performing speciation analysis in urine samples with very low concentrations, it is often only the major species that is above the limit of detection, leading to nearly 100% DMA in this case. Because of the influence of food and analytical precision on the percentage of DMA (%DMA) in the low concentration range, we decided to evaluate factors that influence the metabolite pattern only at concentrations > 2 mug/L, at which the influence from food was less obvious. Furthermore, 11 individuals were also excluded because they had high urinary arsenic concentrations and low water arsenic concentrations in combination with a high percentage of DMA in the urine, indicating a significant contribution to the exposure via food. The sample size after these exclusions was 415 individuals.
###end p 20
###begin title 21
Determination of arsenic compounds with HPLC-HG-ICPMS
###end title 21
###begin p 22
###xml 444 464 444 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-ehp0115-001081">Lindberg et al. 2006</xref>
###xml 576 577 576 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
The arsenic metabolites in urine were measured by an inductively coupled plasma mass spectrometer (ICPMS; HP 4500 or Agilent 7500cs; Agilent Technologies, Waldbronn, Germany) equipped with an integrated sample introducion system and a hydride generation (HG) accessory together with an Agilent 1100 chromatographic system equipped with solvent degasser, autosampler, and a thermostatted column. The method is described in more detail elswhere (Lindberg et al. 2006). We adjusted the arsenic concentrations in urine to the average specific gravity in the population (1.017 g/cm3) using a refractometer (Leica TS 400 Refractometer; Leica Microsystems Inc., Buffalo, NY, USA) to compensate for variation in dilution.
###end p 22
###begin title 23
Determination of selenium in blood
###end title 23
###begin p 24
###xml 228 231 228 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
Selenium in whole blood was analyzed at a commercial laboratory (Analytica AB, Lulea, Sweden) with an inductively coupled plasma sector field mass spectrometer (ELEMENT, ThermoElectron; Finnigan MAT, Bremen, Germany) monitoring m/z 78 in high-resolution mode (delta m/m = 11,000). Samples were prepared by 25-fold dilution with ammonia:Triton X:EDTA:ethanol mixture (2%:0.0005%:0.0005%:4%) with addition of arsenic at 10 ng/mL for internal standardization. Calibration was performed externally with matrix-matched standards. Accuracy and precision of the method were controlled by analysis of a commercial reference material (Seronorm SN ok0336; SERO AS, Billingstad, Norway).
###end p 24
###begin title 25
Genotyping
###end title 25
###begin p 26
###xml 212 217 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 252 302 252 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-ehp0115-001081">National Center for Biotechnology Information 2007</xref>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 576 598 576 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52-ehp0115-001081">Thirumaran et al. 2006</xref>
###xml 772 779 772 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1-ehp0115-001081">Table 1</xref>
DNA was isolated from blood samples from both cases and controls using Qiagen mini-preparation kits (Qiagen GmbH, Hilden, Germany) and genotyped for single nucleotide polymorphisms (SNPs) in the following genes: MTHFR (Unigene accession no. Hs.214142; National Center for Biotechnology Information 2007), GSTO1 (Hs.190028), and AS3MT (Hs.34492). The SNPs selected for the analysis were non-synonymous with a minor allele frequency of at least 10%. We performed genotyping using the 5' nuclease allelic discrimination assay (TaqMan) in 96-well format, as described previously (Thirumaran et al. 2006). TaqMan primers and probes were purchased from Applied Biosystems (Foster City, CA, USA) as "Assays-by-Design." Primer and probe sequences used for genotyping are shown in Table 1. Polymerase chain reaction (PCR) was performed in a 5-10 muL volume reaction using 5 ng DNA as template, premade master mix, and 0.5x probe-primer mix. The initial temperature conditions for PCR were set at 50degreesC for 2 min and 95degreesC for 10 min, followed by 35-40 cycles at 92degreesC for 15 sec and 60degreesC for 1 min. Genotyping on amplified PCR products was scored by differences in fluorescent levels of VIC and FAM (both from Applied Biosystems) in plates read on an ABI PRISM 7900HT sequence detection system using SDS 1.2 software (Applied Biosystems). Postoperation data were transferred as Microsoft Excel data (Microsoft Corporation, Redmond, WA, USA) and converted into genotype information.
###end p 26
###begin title 27
Direct DNA sequencing
###end title 27
###begin p 28
###xml 349 356 349 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1-ehp0115-001081">Table 1</xref>
We randomly verified 4% of genotyping results from allelic discrimination assays by direct DNA sequencing. The sequencing reactions were performed using the BigDyeR Terminator Cycle sequencing kit (Applied Biosystems) in a 10-mL volume containing PCR product pretreated with ExoSapIT (Amersham Biosciences, Uppsala, Sweden) and a sequencing primer (Table 1). The temperature conditions set for sequencing reactions were 96degreesC for 2 min followed by 27 cycles at 96degreesC for 30 sec, 54degreesC for 10 sec, and 60degreesC for 4 min. Sequencing reaction products were precipitated with 2-propanol, washed with 75% ethanol, resuspended in 25 mL water, and loaded onto an ABI Prism 3100 Genetic Analyzer (Applied Biosystems). Primary sequencing data were analyzed using a sequence analysis program (Applied Biosystems).
###end p 28
###begin title 29
Statistical analyses
###end title 29
###begin p 30
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 473 474 473 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sub>
###xml 473 474 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>s</sub></italic>
###xml 581 582 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 1450 1451 1450 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 1451 1452 1451 1452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1660 1661 1660 1661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1675 1676 1675 1676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1717 1727 1717 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b59-ehp0115-001081">WHO (2000)</xref>
###xml 1871 1872 1871 1872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1925 1926 1925 1926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
To evaluate whether selection in favor of a specific genotype had occurred, we assessed the Hardy-Wienberg equilibrium using allele frequencies. Statistica 7.1 for Windows (StatSoft Inc., Tulsa, OK, USA) was used to perform the statistical analyses. In the multivariate analyses using linear regression, the variables were natural log (ln)-transformed as needed to meet the requirement of equal variance and normal distribution of residuals. We used Spearman correlation (rs) when testing for univariate associations between continuous variables. Nonparametric tests (Mann-Whitney U-test and Kruskal-Wallis test) were used in testing for univariate differences between groups. We used one-way analysis of variance when testing for univariate differences between genotypes and Pearson chi-square when testing for differences between categorical variables. The multiple regression models, including all individuals, included variables that were significantly associated with any of the relative proportions of arsenic metabolites in the uni-variate tests. The multiple regression models stratified by sex included the variables that were significantly associated with any of the proportions of arsenic metabolites in the multiple regression models, including all individuals. Tests for collinearity were performed using tolerance. We included BMI in the models instead of body surface area (BSA) because BMI gave a higher coefficient of determination (R2) compared with BSA. When testing for differences in subgroups (except sex), we used analysis of covariance with dichotomized independent variables [age, above a mean of 60 years or < 60 years; BMI, > 25 kg/m2 and < 25 kg/m2, the limit of overweight defined by the WHO (2000)] adjusted for continuous covariates that were significant in the multiple regression analyses that included all individuals. We generally used p < 0.05 to indicate statistical significance, except p < 0.10 was used for some interactions.
###end p 30
###begin title 31
Results
###end title 31
###begin title 32
Descriptive
###end title 32
###begin p 33
###xml 53 60 53 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2-ehp0115-001081">Table 2</xref>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 375 376 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 483 484 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 531 532 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 542 543 542 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 644 645 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1113 1120 1113 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2-ehp0115-001081">Table 2</xref>
###xml 1380 1385 1377 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 1401 1406 1396 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 1422 1427 1415 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 1447 1452 1438 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 1480 1487 1471 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2-ehp0115-001081">Table 2</xref>
###xml 1664 1669 1655 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 27 39 <span type="species:ncbi:9606">participants</span>
###xml 204 207 <span type="species:ncbi:9606">men</span>
###xml 223 228 <span type="species:ncbi:9606">women</span>
###xml 394 406 <span type="species:ncbi:9606">participants</span>
###xml 457 460 <span type="species:ncbi:9606">men</span>
###xml 476 481 <span type="species:ncbi:9606">women</span>
The characteristics of the participants are shown in Table 2. A total of 225 males and 190 females, 60 years of age on average, were included in the study. Twenty percent were current smokers (26% of the men and 14% of the women; p < 0.001). The current smokers were younger (mean age, 53 years) than ex-smokers and nonsmokers (mean age, 62 years and 65 years, respectively; p < 0.001). Of the participants, 83% had consumed any kind of alcohol (95% of the men and 70% of the women; p < 0.001). The average BMI and BSA were 27 kg/m2 and 1.9 m2, respectively. We found a positive correlation between selenium in whole blood and urinary arsenic (p < 0.001). The main reason for this correlation was that the individuals from Hungary had both higher urinary arsenic concentrations and higher blood selenium concentrations than individuals form Romania and Slovakia. Among the Hungarians, Romanians, or Slovakians, analyzed separately, we found no association between arsenic and selenium concentrations. The average proportions of iAs (%iAs), MA (%MA), and DMA (%DMA) in urine were 8.3%, 17%, and 73%, respectively (Table 2). However, there were wide variations. We were able to detect traces of MA(III) in only two samples (0.23 and 0.25 mug/L, respectively) corresponding to 0.89 and 6.6% of the total arsenic metabolites. The allele and genotype frequencies for the A222V (C-->T) MTHFR, E429A (A-->C) MTHFR, A140D (C-->A) GSTO1, and M287T (T-->C) AS3MT polymorphisms are shown in Table 2. The genotype distributions for all polymorphisms were in accordance with the Hardy-Weinberg distribution. Only three individuals were homozygous for the variant allele in the AS3MT gene and were therefore combined with the heterozygotes for further analyses. Genotype distributions were not associated with sex or country.
###end p 33
###begin title 34
Univariate analyses
###end title 34
###begin p 35
###xml 21 22 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 40 41 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 68 69 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 131 132 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 179 180 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 279 280 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 426 431 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 462 463 460 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 542 543 540 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 552 560 550 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2-ehp0115-001081">Figure 2</xref>
###xml 647 652 643 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 682 683 678 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 709 710 705 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 720 728 716 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2-ehp0115-001081">Figure 2</xref>
###xml 0 3 <span type="species:ncbi:9606">Men</span>
###xml 84 89 <span type="species:ncbi:9606">women</span>
Men had higher %iAs (p = 0.04) and %MA (p = 0.003), and lower %DMA (p = 0.008) than women. BMI was negatively associated with %MA (p = 0.001) and positively associated with %DMA (p = 0.003), but it was not associated with %iAs. Blood selenium was positively associated with %MA (p < 0.001) and negatively associated with %DMA (p = 0.007), but not with %iAs. Individuals homozygous for the variant allele for the A222V (C-->T) MTHFR polymorphisms had lower %DMA (p = 0.002) and higher %MA than individuals homozygous for the wild-type allele (p = 0.01; Figure 2). Individuals heterozygous and homozygous for the variant allele in the M287T (T-->C) AS3MT polymorphism had lower %DMA (p = 0.003) and higher %MA (p < 0.001; Figure 2). The concentration of total urinary arsenic, smoking, or alcohol use were not associated with %iAs, %MA, or %DMA.
###end p 35
###begin title 36
Multivariate analyses
###end title 36
###begin p 37
###xml 51 58 51 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3-ehp0115-001081">Table 3</xref>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 254 259 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 470 476 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT,</italic>
###xml 524 529 524 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 696 701 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 790 791 790 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 811 812 811 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 889 890 887 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 968 969 966 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
We designed one model for each arsenic metabolite. Table 3 shows the results of the multiple regression analyses to test whether the distributions of urinary arsenic metabolites were dependent on sex, age, BMI, selenium, and gene polymorphisms in MTHFR, GSTO1, and AS3MT. Similar to the univariate assessment, %DMA was associated with polymorphisms in AS3MT and MTHFR genes, selenium, BMI, and sex in decreasing order. The %MA was associated with a gene polymorphism in AS3MT, selenium, BMI, sex, and a gene polymorphism in MTHFR in decreasing order. However, for %iAs the multivariate analyses showed only an association with sex and an almost significant association with a polymorphism in the MTHFR gene. For %MA, we found a significant interaction between BMI (two categories: > 25 kg/m2 and below < 25 kg/m2) and selenium (two categories: above the median of 99 mug/L and > 99 mug/L; p = 0.06). Also, the corresponding interaction for %DMA was near significance (p = 0.10).
###end p 37
###begin p 38
###xml 151 158 151 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4-ehp0115-001081">Table 4</xref>
###xml 214 219 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 365 370 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 744 753 744 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3-ehp0115-001081">Figure 3A</xref>
###xml 839 848 839 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3-ehp0115-001081">Figure 3B</xref>
###xml 769 772 <span type="species:ncbi:9606">men</span>
###xml 832 837 <span type="species:ncbi:9606">women</span>
To better understand the difference in methylation capacity between males and females, we repeated the multiple regression analyses stratified by sex (Table 4). The sex-specific models show that selenium, BMI, and AS3MT polymorphisms affect the distribution of urinary arsenic metabolites in males, but not in females. Also, in males, mutation in one allele in the MTHFR gene altered the pattern of urinary arsenic metabolites; however, for females, mutations of both alleles were required. Furthermore, to test whether the sex difference in methylation capacity was dependent on age or BMI, we used analysis of covariance. In those < 60 years of age, males had a higher %MA than females, but this was not the case for those > 60 years of age (Figure 3A). Furthermore, men of normal weight had a higher %MA than overweight or obese women (Figure 3B).
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 81 86 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 131 136 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
The results of the present study show that the M287T (T-->C) polymorphism in the AS3MT gene, the A222V (C-->T) polymorphism in the MTHFR gene, BMI, and sex are major factors that influence arsenic metabolism in this Central European population. This is the first study to our knowledge to elucidate factors influencing the metabolism of iAs at these low concentrations, where the influence of arsenic exposure on the methylation reactions is negligible. It is also the first to study arsenic-related polymorphisms in Europe.
###end p 40
###begin p 41
###xml 150 164 150 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40-ehp0115-001081">PharmGKB 2007a</xref>
###xml 166 171 166 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41-ehp0115-001081">2007b</xref>
###xml 173 178 173 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42-ehp0115-001081">2007c</xref>
###xml 180 185 180 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43-ehp0115-001081">2007d</xref>
###xml 292 297 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 347 363 345 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-ehp0115-001081">Meza et al. 2005</xref>
###xml 380 411 378 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45-ehp0115-001081">Schl&#228;wicke Engstr&#246;m et al. 2006</xref>
###xml 438 443 436 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 651 656 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 804 828 802 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31-ehp0115-001081">Martin and McMillan 2002</xref>
###xml 861 869 859 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 977 982 975 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 995 1013 993 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-ehp0115-001081">Drobna et al. 2006</xref>
###xml 1079 1084 1075 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 792 797 <span type="species:ncbi:9606">human</span>
###xml 1109 1114 <span type="species:ncbi:9606">women</span>
###xml 1128 1131 <span type="species:ncbi:9606">men</span>
###xml 1162 1167 <span type="species:ncbi:9606">women</span>
We found the allele frequencies to be in accordance with those in other Caucasian populations, but different from those in several other populations (PharmGKB 2007a, 2007b, 2007c, 2007d). In contrast to our finding that carriers of the variant allele of the M287T (C-->T) polymorphism of the AS3MT gene had higher %MA, previous studies in Mexico (Meza et al. 2005) and Argentina (Schlawicke Engstrom et al. 2006) have shown other SNPs in AS3MT gene to be associated with lower %MA. However, we did not find those SNPs in the present study. Thus, different SNPs in this gene influence the metabolism of iAs in different directions. It is unlikely that AS3MT is the only methyl-transferase that methylates arsenic, given that there are around 100 different methyltransferases identified in the human body (Martin and McMillan 2002). This is supported by a recent in vitro study in which the %DMA was reduced from 53% in the normal cell line to 11% in the cell line with silenced AS3MT expression (Drobna et al. 2006). Interestingly, we found that the M287T (C-->T) polymorphism in AS3MT was not as important in women as it was in men, who also had higher %MA than women.
###end p 41
###begin p 42
###xml 44 49 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 87 92 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 256 258 254 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 273 281 271 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-ehp0115-001081">Figure 1</xref>
###xml 401 417 397 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-ehp0115-001081">Baum et al. 2004</xref>
###xml 865 885 861 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15-ehp0115-001081">Fukagawa et al. 2000</xref>
###xml 1112 1114 1108 1110 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 1144 1155 1140 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-ehp0115-001081">Martin 2006</xref>
###xml 1136 1142 <span type="species:ncbi:9606">people</span>
Also, the A222V (C-->T) polymorphism in the MTHFR gene was associated with higher %MA. MTHFR reduces methylenetetra-hydrofolate to methyltetrahydrofolate, which regenerates methionine from homocysteine in the one-carbon metabolism with methylated vitamin B12 as co-factor (Figure 1). The A222V (C-->T) polymorphism has been associated with reduced enzyme activity and elevated levels of homocysteine (Baum et al. 2004), which in turn could lead to lower SAM-dependent methylation via feedback inhibition, possibly explaining our results. An interesting finding in the present study was that mutation on only one allele was needed to alter the arsenic metabolite pattern in males, whereas females needed mutations on both alleles. This discrepancy could be because females have a generally higher rate of remethylation of methionine from homocysteine than do males (Fukagawa et al. 2000). Furthermore, the influence of the A222V polymorphism on the metabolite pattern was more pronounced in individuals > 60 years of age (data not shown). The elderly are known to have poorer nutrition, especially lower vitamin B12 levels, than younger people (Martin 2006), which could make them more susceptible to the reduced enzyme activity that might result from the polymorphism.
###end p 42
###begin p 43
###xml 0 21 0 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-ehp0115-001081">Marnell et al. (2003)</xref>
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 301 322 301 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-ehp0115-001081">Chowdhury et al. 2006</xref>
###xml 386 391 386 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
Marnell et al. (2003) observed that two individuals with an uncommon genotype of GSTO1 had an altered distribution of iAs metabolites in urine. However, studies with GSTO1 knockout mice showed that they still reduced arsenic(V) species, but to a lesser extent (~ 20% of that found in wild-type mice) (Chowdhury et al. 2006). This animal study supports our finding that polymorphisms in GSTO1 are not associated with an altered arsenic metabolite pattern, indicating nonenzymatic reduction and/or the presence of alternative enzymes for these reduction reactions.
###end p 43
###begin p 44
###xml 227 245 227 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16-ehp0115-001081">Gamble et al. 2005</xref>
###xml 247 265 247 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33-ehp0115-001081">Milton et al. 2004</xref>
###xml 267 284 267 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-ehp0115-001081">Mitra et al. 2004</xref>
###xml 286 307 286 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50-ehp0115-001081">Steinmaus et al. 2005</xref>
###xml 547 548 547 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 989 1010 989 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38-ehp0115-001081">Nelson and Bulun 2001</xref>
###xml 1153 1171 1153 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44-ehp0115-001081">Pugeat et al. 1995</xref>
###xml 626 629 <span type="species:ncbi:9606">men</span>
###xml 655 660 <span type="species:ncbi:9606">women</span>
Several studies have shown associations between malnourishment and increased risk for different arsenic induced health effects, partly due to less antioxidant defense and partly due to alterations in the metabolism of arsenic (Gamble et al. 2005; Milton et al. 2004; Mitra et al. 2004; Steinmaus et al. 2005). In the present study, we observed an increase in %DMA and a decrease in %MA and %iAs with increasing BMI. However, this association was probably not due to nutritional factors because most individuals were overweight (median BMI, 27 kg/m2). The BMI-related difference in methylation was mainly between normal-weight men and overweight and obese women, and we found a difference between the sexes in arsenic methylation only in individuals < 60 years of age; therefore, the results may suggest that sex steroids influence the methylation of arsenic. Estrogen is produced in adipose tissue in both males and females, leading to higher levels of estrogen in overweight individuals (Nelson and Bulun 2001). Furthermore, sex hormone-binding globulin is reduced with increasing body weight, leading to the release of free estrogen and progesterone (Pugeat et al. 1995). However, more studies are needed on differences between the sexes and the influence of sex steroids on the metabolism of arsenic.
###end p 44
###begin p 45
###xml 104 125 104 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp0115-001081">Christian et al. 2006</xref>
###xml 127 144 127 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-ehp0115-001081">Hsueh et al. 2003</xref>
###xml 843 864 838 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-ehp0115-001081">Bat&#225;riov&#225; et al. 2005</xref>
###xml 866 893 861 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57-ehp0115-001081">Van Cauwenbergh et al. 1990</xref>
Our hypothesis was that selenium would increase the methylation capacity, as shown in previous reports (Christian et al. 2006; Hsueh et al. 2003). However, the present study indicated the opposite association with selenium. When further evaluation of the interaction between selenium and BMI was performed, it appeared that Romanians and Slovakians had lower blood selenium but higher fractions of methylated metabolites of arsenic in urine compared with the Hungarians. Therefore, the association between %DMA or %MA and selenium was probably not a causal association, but rather an effect of, for example, different food habits in the different countries. The selenium concentrations (mean +/- SD, 100 +/- 22 mug/L) do not indicate deficiency, and the concentrations were in the same range as reported in several other European populations (Batariova et al. 2005; Van Cauwenbergh et al. 1990).
###end p 45
###begin p 46
###xml 127 153 127 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-ehp0115-001081">Hopenhayn-Rich et al. 1996</xref>
###xml 155 172 155 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-ehp0115-001081">Hsueh et al. 2003</xref>
We were not able to confirm previous findings that smoking and alcohol consumption negatively influence the metabolism of iAs (Hopenhayn-Rich et al. 1996; Hsueh et al. 2003). However, this was probably because of the low arsenic exposure in the present study.
###end p 46
###begin p 47
###xml 217 237 217 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-ehp0115-001081">Feldmann et al. 1999</xref>
###xml 772 792 772 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp0115-001081">Aposhian et al. 2000</xref>
###xml 794 808 794 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-ehp0115-001081">Le et al. 2000</xref>
###xml 810 828 810 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-ehp0115-001081">Mandal et al. 2001</xref>
###xml 830 852 830 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56-ehp0115-001081">Valenzuela et al. 2005</xref>
###xml 934 945 934 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55-ehp0115-001081">Vahter 2002</xref>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
###xml 428 436 <span type="species:ncbi:9606">patients</span>
###xml 627 634 <span type="species:ncbi:9606">patient</span>
###xml 726 731 <span type="species:ncbi:9606">human</span>
Because previous reports have shown the presence of appreciable amounts of MA(III) in human urine and have claimed that improper sampling and storage conditions are likely reasons for the absence of MA(III) in urine (Feldmann et al. 1999), we also analyzed urine samples from patients treated with high levels of arsenic trioxide [30 mg arsenic/week (unpublished data)]. Spot urine samples were collected from four plasmacytoma patients both before and after treatment and immediately frozen in liquid nitrogen until analysis (~ 3 days after collection). A trace amount of MA(III), too low to be quantifiable, was found in one patient. The results of the present study indicate that MA(III) is not a significant metabolite in human urine, in contrast to previous reports (Aposhian et al. 2000; Le et al. 2000; Mandal et al. 2001; Valenzuela et al. 2005). Our interpretation is that the high reactivity renders them to bind in tissue (Vahter 2002).
###end p 47
###begin p 48
In conclusion, the present study shows that polymorphisms in genes coding for enzymes involved in the metabolism of iAs explains a part of the large interindividual variation seen in the metabolism of iAs, especially in males, although not as much as we hypothesized. Other methyltransferases are probably backing up the methylation of arsenic. Genes coding for enzymes involved in the metabolism of iAs, as well as the influence of polymorphisms in these genes on metabolism, have only recently been investigated in epidemiologic studies. More large-scale studies are needed for complete understanding of arsenic metabolism.
###end p 48
###begin title 49
References
###end title 49
###begin article-title 50
###xml 102 105 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">III</sup>
###xml 120 125 <span type="species:ncbi:9606">human</span>
DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMAIII), excreted in human urine
###end article-title 50
###begin article-title 51
Whole blood selenium content in healthy adults in the Czech Republic
###end article-title 51
###begin article-title 52
Methylenetetrahydrofolate reductase gene A222V polymorphism and risk of ischemic stroke
###end article-title 52
###begin article-title 53
Arsenic methylation and skin cancer risk in southwestern Taiwan
###end article-title 53
###begin article-title 54
###xml 34 41 <span type="species:ncbi:4097">tobacco</span>
Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer
###end article-title 54
###begin article-title 55
Arsenic methylation and bladder cancer risk in Taiwan
###end article-title 55
###begin article-title 56
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration
###end article-title 56
###begin article-title 57
###xml 60 65 <span type="species:ncbi:9606">women</span>
Distribution of urinary selenium and arsenic among pregnant women exposed to arsenic in drinking water
###end article-title 57
###begin article-title 58
Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study
###end article-title 58
###begin article-title 59
###xml 35 41 <span type="species:ncbi:9986">rabbit</span>
Complexation of arsenic species in rabbit erythrocytes
###end article-title 59
###begin article-title 60
Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study
###end article-title 60
###begin article-title 61
shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells
###end article-title 61
###begin article-title 62
A formula to estimate the approximate surface area if height and weight be known
###end article-title 62
###begin article-title 63
###xml 64 69 <span type="species:ncbi:9606">human</span>
Sample preparation and storage can change arsenic speciation in human urine
###end article-title 63
###begin article-title 64
Sex-related differences in methionine metabolism and plasma homocysteine concentrations
###end article-title 64
###begin article-title 65
Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh
###end article-title 65
###begin article-title 66
###xml 86 91 <span type="species:ncbi:9606">human</span>
A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19
###end article-title 66
###begin article-title 67
Methylation study of a population environmentally exposed to arsenic in drinking water
###end article-title 67
###begin article-title 68
Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer
###end article-title 68
###begin article-title 69
Determinants of inorganic arsenic methylation capability among residents of the Lanyang Basin, Taiwan: arsenic and selenium exposure and alcohol consumption
###end article-title 69
###begin article-title 70
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
Dose-dependent effects on the disposition of monomethylarsonic acid and dimethyl-arsinic acid in the mouse after intravenous administration
###end article-title 70
###begin article-title 71
Some Drinking-Water Disinfectants and Contaminants, including Arsenic
###end article-title 71
###begin article-title 72
Insights into the carcinogenic mode of action of arsenic
###end article-title 72
###begin article-title 73
###xml 85 90 <span type="species:ncbi:9606">human</span>
Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine
###end article-title 73
###begin article-title 74
###xml 8 9 8 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 68 71 <span type="species:ncbi:10116">rat</span>
A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol
###end article-title 74
###begin article-title 75
Arsenic exposure in Hungary, Romania and Slovakia
###end article-title 75
###begin article-title 76
###xml 73 78 <span type="species:ncbi:9606">human</span>
Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water
###end article-title 76
###begin article-title 77
###xml 67 72 <span type="species:ncbi:9606">human</span>
Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India
###end article-title 77
###begin article-title 78
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sup>
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hGSTO1</italic>
###xml 21 26 <span type="species:ncbi:9606">human</span>
Polymorphisms in the human monomethylarsonic acid (MMAV) reductase/hGSTO1 gene and changes in urinary arsenic profiles
###end article-title 78
###begin article-title 79
Vitamins for the elderly: from A to zinc
###end article-title 79
###begin article-title 80
###xml 26 27 26 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold
###end article-title 80
###begin article-title 81
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYT19</italic>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 151 159 <span type="species:ncbi:9606">children</span>
Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children
###end article-title 81
###begin article-title 82
Association between nutritional status and arsenicosis due to chronic arsenic exposure in Bangladesh
###end article-title 82
###begin article-title 83
Nutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, India
###end article-title 83
###begin article-title 84
Trivalent arsenicals are bound to proteins during reductive methylation
###end article-title 84
###begin article-title 85
Estrogen production and action
###end article-title 85
###begin article-title 86
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">III</sup>
###xml 70 75 <span type="species:ncbi:9606">human</span>
Monomethylarsonous acid (MMAIII) is more toxic than arsenite in Chang human hepatocytes
###end article-title 86
###begin article-title 87
Interrelations between sex hormone-binding globulin (SHBG), plasma lipoproteins and cardiovascular risk
###end article-title 87
###begin article-title 88
Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina
###end article-title 88
###begin article-title 89
###xml 122 127 <span type="species:ncbi:9606">human</span>
Arsenite and its bio-methylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg
###end article-title 89
###begin article-title 90
###xml 115 120 <span type="species:ncbi:9606">human</span>
Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA
###end article-title 90
###begin article-title 91
Reactions of arsenic(III) and arsenic(V) species with glutathione
###end article-title 91
###begin article-title 92
Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States
###end article-title 92
###begin article-title 93
Dietary intake and arsenic methylation in a U.S. population
###end article-title 93
###begin article-title 94
###xml 89 92 <span type="species:ncbi:10116">rat</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells
###end article-title 94
###begin article-title 95
Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin
###end article-title 95
###begin article-title 96
###xml 13 18 <span type="species:ncbi:9606">human</span>
Variation in human metabolism of arsenic
###end article-title 96
###begin article-title 97
Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity
###end article-title 97
###begin article-title 98
Mechanisms of arsenic biotransformation
###end article-title 98
###begin article-title 99
Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic
###end article-title 99
###begin article-title 100
Selenium concentration levels in whole blood of Belgian blood bank donors, as determined by direct graphite furnace atomic absorption spectrometry
###end article-title 100
###begin article-title 101
###xml 116 121 <span type="species:ncbi:9606">human</span>
Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes
###end article-title 101
###begin article-title 102
Obesity: Preventing and Managing the Global Epidemic
###end article-title 102
###begin article-title 103
Arsenic and Arsenic Compounds
###end article-title 103
###begin article-title 104
Arsenic methylation capacity and skin cancer
###end article-title 104
###begin article-title 105
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sup>
###xml 77 78 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human monomethylarsonic acid (MMAV) reductase is a member of the glutathione-S-transferase superfamily
###end article-title 105
###begin p 106
Financial support was provided by EC project QLK4-CT-2001-00264 (ASHRAM).
###end p 106
###begin p 107
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">As3MT</italic>
###xml 235 236 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 264 265 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 296 298 296 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 361 362 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 408 409 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
The methionine and folic acid cycles and the metabolic pathway of arsenic. Abbreviations: 5-CH3-THF, methyl tetrahydrofolate; 5,10-CH2-THF, methylenetetrahydrofolate; As3MT, arsenic (+3 oxidation state) methyltransferase; B2, vitamin B2 (riboflavin); B6, vitamin B6; CH3-B12, methylated vitamin B12; DHF, dihydrofolate; DMG, dimethylglycine; GSTO1, glutathione-S-transferase omega; HCy, homocysteine; SAHCy, S-adenosyl homocysteine; THF, tetrahydrofolate; Zn, zinc.
###end p 107
###begin p 108
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTHFR</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTO1</italic>
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 133 134 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
The mean and confidence interval of the %MA by genotype of MTHFR A222V, MTHFR E429A, GSTO1 A140D, and AS3MT M287T for (A) males and (B) females.
###end p 108
###begin p 109
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>a</italic></bold>
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><bold><italic>a</italic></bold></sup>
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AS3MT</italic>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
aHeterozygotes and homozygotes for the varient allele in the AS3MT polymorphism are combined. *p = 0.01. **p < 0.001.
###end p 109
###begin p 110
###xml 48 49 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
The mean and confidence interval of %MA by age (A) and BMI (B) in males and females.
###end p 110
###begin p 111
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</italic>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>*</italic></bold>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 10 12 10 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">**</italic>
###xml 10 12 10 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>**</italic></bold>
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p = 0.03.**p = 0.04.
###end p 111
###begin p 112
Primers and probes used for SNP genotyping, including primer sequences, annealing temperatures, and fragment sizes of the amplified products used for PCR amplification and direct DNA sequencing.
###end p 112
###begin p 113
Abbreviations: F, forward; R, reverse; Temp, temperature,
###end p 113
###begin p 114
###xml 0 11 <span type="species:ncbi:9606">Participant</span>
Participant characteristics, data on exposure, proportions of urinary arsenic species and genotype frequencies.
###end p 114
###begin p 115
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 89 90 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Calculated as body weight (kg)/height (m)2; normal, 18.5-25 kg/m2; overweight, 25-30 kg/m2; obese, > 30 kg/m2.
###end p 115
###begin p 116
###xml 30 35 30 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0.425</sup>
###xml 49 54 49 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0.725</sup>
###xml 67 89 67 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13-ehp0115-001081">DuBois and DuBois 1916</xref>
Calculated as body weight (kg)0.425 x height (cm)0.725 x 0.007184 (DuBois and DuBois 1916).
###end p 116
###begin p 117
Sum of iAs, MA, and DMA in urine.
###end p 117
###begin p 118
Multiple regression analyses to test whether %DMA, %MA, and %iAs are dependent on sex, age, BMI, selenium, and some polymorphisms.
###end p 118
###begin p 119
Male = 0; female = 1.
###end p 119
###begin p 120
Unstandardized regression coefficient.
###end p 120
###begin p 121
Standardized regression coefficient.
###end p 121
###begin p 122
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p < 0.05.
###end p 122
###begin p 123
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p < 0.01.
###end p 123
###begin p 124
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="tfn10-ehp0115-001081">a</xref>
Multiple regression analyses separated by sex to test whether %DMA, %MA, and %iAs are dependent on sex, BMI, selenium, and some polymorphisms.a
###end p 124
###begin p 125
Standardized regression coefficients (beta).
###end p 125
###begin p 126
For age < 60 years, 0; for age >/= 60 years, 1.
###end p 126
###begin p 127
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 42 43 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
For BMI < 25 kg/m2, 0; for BMI >/= 25 kg/m2, 1.
###end p 127
###begin p 128
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p < 0.10.
###end p 128
###begin p 129
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
p < 0.05.
###end p 129

